Literature DB >> 27965281

Influence of potassium-competitive acid blocker on the gut microbiome of Helicobacter pylori-negative healthy individuals.

Taketo Otsuka1, Mitsushige Sugimoto2, Ryo Inoue3, Masashi Ohno1, Hiromitsu Ban2, Atsushi Nishida1, Osamu Inatomi1, Shunsuke Takahashi4, Yuji Naito5, Akira Andoh1.   

Abstract

Entities:  

Keywords:  ACID SECRETION; GUT INFLAMMATION; INTESTINAL MICROBIOLOGY

Mesh：

Substances：

Year:  2016        PMID： 27965281     DOI： 10.1136/gutjnl-2016-313312

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Influence of proton pump inhibitors on microbiota in chronic liver disease patients.

Authors:  Kenta Yamamoto; Masatoshi Ishigami; Takashi Honda; Tomoaki Takeyama; Takanori Ito; Yoji Ishizu; Teiji Kuzuya; Kazuhiko Hayashi; Hidemi Goto; Yoshiki Hirooka
Journal:  Hepatol Int       Date:  2019-02-08       Impact factor: 6.047

Review 2.  Novel Therapies for Gastroesophageal Reflux Disease: Beyond Proton Pump Inhibitors.

Authors:  Fahmi Shibli; Yoshitaka Kitayama; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

3.  Gut Microbiota Composition Before and After Use of Proton Pump Inhibitors.

Authors:  Mariko Hojo; Takashi Asahara; Akihito Nagahara; Tsutomu Takeda; Kohei Matsumoto; Hiroya Ueyama; Kenshi Matsumoto; Daisuke Asaoka; Takuya Takahashi; Koji Nomoto; Yuichiro Yamashiro; Sumio Watanabe
Journal:  Dig Dis Sci       Date:  2018-05-24       Impact factor: 3.199

Review 4.  Potent Potassium-competitive Acid Blockers: A New Era for the Treatment of Acid-related Diseases.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2018-07-30       Impact factor: 4.924

Review 5.  Role of Acid Suppression in Acid-related Diseases: Proton Pump Inhibitor and Potassium-competitive Acid Blocker.

Authors:  Hideki Mori; Hidekazu Suzuki
Journal:  J Neurogastroenterol Motil       Date:  2019-01-31       Impact factor: 4.924

Review 6.  Potassium-competitive acid blockers and gastroesophageal reflux disease.

Authors:  Wattana Leowattana; Tawithep Leowattana
Journal:  World J Gastroenterol       Date:  2022-07-28       Impact factor: 5.374

Review 7.  The role of vonoprazan in patients with erosive esophagitis.

Authors:  Mengyu Zhang; Yinglian Xiao; Minhu Chen
Journal:  Therap Adv Gastroenterol       Date:  2022-09-13       Impact factor: 4.802

Review 8.  Mechanisms of proton pump inhibitor-induced hypomagnesemia.

Authors:  Lisanne M M Gommers; Joost G J Hoenderop; Jeroen H F de Baaij
Journal:  Acta Physiol (Oxf)       Date:  2022-06-14       Impact factor: 7.523

Review 9.  Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.

Authors:  Kentaro Sugano
Journal:  Therap Adv Gastroenterol       Date:  2018-01-09       Impact factor: 4.409

10.  The influence of long-term use of proton pump inhibitors on the gut microbiota: an age-sex-matched case-control study.

Authors:  Tomohisa Takagi; Yuji Naito; Ryo Inoue; Saori Kashiwagi; Kazuhiko Uchiyama; Katsura Mizushima; Saeko Tsuchiya; Tetsuya Okayama; Osamu Dohi; Naohisa Yoshida; Kazuhiro Kamada; Takeshi Ishikawa; Osamu Handa; Hideyuki Konishi; Kayo Okuda; Yoshimasa Tsujimoto; Hiromu Ohnogi; Yoshito Itoh
Journal:  J Clin Biochem Nutr       Date:  2017-12-12       Impact factor: 3.114
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.